FDA Inspection 1116449 — Garonit Pharmaceutical, Inc.

Garonit Pharmaceutical, Inc. — FEI 3003961853

The FDA completed an inspection of Garonit Pharmaceutical, Inc. on Jan 14, 2020 in Fairfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 14, 2020
Fiscal Year
2020
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Fairfield, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.